In conclusion, we have demonstrated an epigenetic mechanism by which HBx induces renal EMT and inflammation and uncovered a vital characteristic of the DNMT1 inhibitor with respect to preventing and treating HBV-GN. This evidence concerns the gene DNMT1 and ganglioneuroma.